Efficacy of accelerated hepatitis B vaccination program in patients being actively treated for hematologic malignancies

International Journal of Infectious Diseases

Volumn 12, Issue 2, 2008, Pages 166-170

  Pullukcu, Husnu ^a   Ertem, Ekin ^a   Karaca, Yildiray ^b   Yamazhan, Tansu ^a   Sertoz, Ruchan Yazan ^a   Altuglu, Imre ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Department of Biochemistry   (Turkey)

Author keywords

Accelerated HBV vaccination; Leukemia; Lymphoma; Protection

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DRUG EFFICACY; FEMALE; HEMATOLOGIC MALIGNANCY; HEPATITIS B; HUMAN; MALE; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; SEX DISTRIBUTION; VACCINATION;

EID: 39049140176     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.06.004     Document Type: Article

References (27)

1. Besisik F., and Besisik F.S. [The problem of chronic viral hepatitis in the immune compromised] (in Turkish). In: Tabak F., Bali{dotless}k I., and Tekeli E. (Eds). Viral hepatit 2005 (2005), Viral Hepatitle Savaşi{dotless}m Derneǧi, İstanbul 90-102
2. Trotter J.F. Rapidly progressive hepatitis C mimicking extrahepatic biliary obstruction in non-hepatic solid organ transplant recipients. Hepatology 24 Suppl (1997) 145A
3. Delladetsima J.K., Boletis J.N., Makris F., Psichogiou M., Kostakis A., and Hatzakis A. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transpl Surg 5 (1999) 294-300
4. Flowers M.A., Heathcote J., Wanless I.R., Sherman M., Reynolds W.J., Cameron R.G., et al. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy. Ann Intern Med 112 (1990) 381-382
5. Yeo W., Zee B., Zhong S., Chan P.K., Wong W.L., Ho W.M., et al. Comprehensive analysis of risk factors associating with hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer 90 (2004) 1306-1311
6. Lau J.Y., Bird G.L., Gimson A.E., Alexander G.J., and Williams R. Treatment of HBV reactivation after withdrawal of immunosuppression. Lancet 337 (1991) 802
7. Lok A.S., Liang R.H., Chiu E.K., Wong K.L., Chan T.K., and Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 100 (1991) 182-188
8. Yeo W., Chan P.K., Zhong S., Ho W.M., Steinberg J.L., Tam J.S., et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 62 (2000) 299-307
9. Pinto P.C., Hu E., Bernstein S.M., Pinter B.L., and Govindarajan S. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 65 (1990) 878-884
10. Sari R., Ozkan H.I., Sevinc A., and Aydogdu I. [Seropositivity of hepatitis B and hepatitis C viruses in blood and blood products in transfused and non-transfused patients with hematological malignancies] (in Turkish). Turgut Ozal Ti{dotless}p Merkezi Dergisi 7 (2000) 109-112
11. Cengiz A.T., Kiyan M., Uysal V.A., and Ugurel M.S. [Investigation of HBsAg in the sera of patients with Hodgkin's disease, non-Hodgkin lymphoma and leukemia] (in Turkish). Turk J Infect 6 (1992) 257-260
12. Haydon G.H., and Mutimer D.J. Hepatitis B and C virus infections in the immune compromised. Curr Opin Infect Dis 16 (2003) 473-479
13. Xunrong L., Yan A.W., Liang R., and Lau G.K. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy-pathogenesis and management. Rev Med Virol 11 (2001) 287-299
14. Liaw Y.F. Hepatitis viruses under immunosuppressive agents. J Gastroenterol Hepatol 13 (1998) 14-20
15. Steinberg J.L., Yeo W., Zhong S., Chan J.Y., Tam J.S., Chan P.K., et al. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role. J Med Virol 60 (2000) 249-255
16. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Gr*oup. Am J Clin Oncol 5 (1982) 649-655
17. François G., Hallauer J., and Van Damme P. Hepatitis B vaccination: how to reach risk groups. Vaccine 21 (2002) 1-4
18. Mistik R, Balik İ. [The analysis of viral hepatitis in Turkey.] Viral hepatit is] 2003 Tekeli E, Bali{dotless}k İ (Eds), Viral Hepatitle Savaşi{dotless}m Derneǧi 2003, sayfa:10-55.
19. Akyol H., Sarialioglu F., Buyukpamukcu M., Karadeniz C., Akyuz C., and Kutluk T. Hepatitis-B Virus infections in pediatric patients receiving anti-cancer chemotherapy. Turk J Cancer 3 (1990) 104-108
20. Tasyaran M.A. [Epidemiology of HBV infections] (in Turkish). In: Tekeli E., and Balik I. (Eds). Viral hepatit 2005 (2003), Viral Hepatitle Savasim Dernegi, Istanbul 121-129
21. Heron L.G., Chant K.G., and Jalaludin B.B. A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart. Vaccine 20 (2002) 3472-3476
22. Hosoglu S., Ayaz C., Ozen A., Kokoglu O.F., and Geyik M.F. [Influence of factors on antibody response to hepatitis B vaccination] (in Turkish). Viral Hepatit Dergisi 1 (1997) 38-41
23. ul-Haq N., Hasnain S.S., Umar M., Abbas Z., Valenzuela-Silva C., and Lopez-Saura P. Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. Vaccine 21 (2003) 3179-3185
24. Goyal S., Pai S.K., Kelkar R., and Advani S.H. Hepatitis B vaccination in acute lymphoblastic leukemia. Leuk Res 22 (1998) 193-195
25. Somjee S., Pai S., Kelkar R., and Advani S. Hepatitis B vaccination in children with acute lymphoblastic leukemia: result of an intensified immunization schedule. Leuk Res 23 (1999) 365
26. Yetgin S., Tunc B., Koc A., Toksoy H.B., Ceyhan M., and Kanra G. Two booster dose hepatitis B virus vaccination in patients with leukemia. Leuk Res 25 (2001) 647-649
27. Ucar C., Oren H., Uysal K., Gulen H., Duman M., and Irken G. [The resultsof hepatitis B vaccination in the patients with hematologic malignancies followed in Dokuz Eylul University Faculty of Medicine hematology unit] (in Turkish). Dokuz Eylul Universitesi Tip Fakultesi Dergisi 15 (2001) 11-15